Search Orphan Drug Designations and Approvals
-
Generic Name: | decitabine and tetrahydrouridine |
---|---|
Date Designated: | 09/19/2016 |
Orphan Designation: | Treatment of sickle cell disease |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Novo Nordisk Inc. 800 Scudders Mill Rd. P.O. Box 846 Plainsboro, New Jersey 08536 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-